- Filed
- Apr 25, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 810.42M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $6.57B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $7.29B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.7B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $660M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.11B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.1B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $363M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $212M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $6.86B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5.76B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $15.91B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $15.5B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $5.81B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $5.32B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $16.65B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $16.05B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 825.9M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $509M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $681M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.83 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.83 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.92B |
| Net Income | Q1 2025 · Mar 31, 2024 | $683M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.05B |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $3.04B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.03B |
| Revenue | Q1 2025 · Mar 31, 2024 | $5.07B |